Major Shareholder Insilico Increases Stake to 38.84% via Open Market Purchase... Positive Signal for Shareholder Value
On May 29, 2026, major shareholder Insilico acquired an additional 9,086 shares of Daesung Microbiological Labs through open market purchases, increasing its stake from 38.60% to 38.84% (a 0.24%p increase).
The acquisition price was 6,746 KRW per share, slightly above the reference market price of 6,650 KRW, indicating willingness to buy at a premium.
This stake increase reflects the major shareholder's confidence in management stability and future enterprise value, and is seen as a factor reinforcing short-term downside price support.
Given the small scale (0.24% of total shares), the immediate price impact is limited, but it serves as a positive signal for long-term investors.
[AI Comprehensive Analysis]A small open-market purchase by a major shareholder is generally positive, but the magnitude of this change is too small to have a material impact on stock price. However, expectations of strengthened control and potential further purchases remain valid.
KOSDAQ Filing Information
Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders